The stock options are exercisable at $0.15 per share, remaining valid for a five-year window following the issuance date. These instruments vest according to the company’s current stock option plan. Simultaneously, the company granted 100,000 restricted share units, which entitle the recipient to receive one common share per unit upon vesting. This specific RSU program received formal backing from shareholders during the annual general and special meeting held in September 2025.
In section Releases
Nanalysis Scientific Grants Equity Incentives to Leadership
Calgary-based Nanalysis Scientific Corp. has issued 100,000 stock options and 100,000 restricted share units to company leadership. The move, disclosed on July 3, 2026, distributes these equity stakes to a director and an officer to align management interests with the firm’s long-term performance objectives under its established compensation plans.
Nanalysis specializes in the development of portable Nuclear Magnetic Resonance spectrometers for global sectors including pharmaceuticals, energy, and security. Beyond its manufacturing operations, the firm manages a significant service division, most notably supported by a $160 million contract to maintain security scanners across more than 80 Canadian airports for the Canadian Air Transport Security Authority.
Comments (0)
No comments yet. Be the first!